Chronic intranigral administration of brain-derived neurotrophic factor produces striatal dopaminergic hypofunction in unlesioned adult rats and fails to attenuate the decline of striatal dopaminergic function following medial forebrain bundle transection
- 1 April 1993
- journal article
- Published by Elsevier in Neuroscience
- Vol. 53 (3) , 639-650
- https://doi.org/10.1016/0306-4522(93)90612-j
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Therapeutic Potential for Nerve Growth Factor in Alzheimer's Disease: Insights from Pharmacological Studies Using Lesioned Central Cholinergic NeuronsReviews in the Neurosciences, 1992
- Neurotrophins in the Central Nervous SystemReviews in the Neurosciences, 1992
- Tyrosine Hydroxylase mRNA Expression by Dopaminergic Neurons in Culture: Effect of 1 -Methyl-4-Phenylpyridinium TreatmentJournal of Neurochemistry, 1991
- Exogenous nerve growth factor stimulates choline acetyltransferase activity in aging Fischer 344 male ratsNeurobiology of Aging, 1991
- Localization of brain-derived neurotrophic factor mRNA to neurons in the brain by in situ hybridizationExperimental Neurology, 1990
- Combined in situ hybridization and immunocytochemistry in the assay of pharmacological effects on tyrosine hydroxylase mRNA concentrationPharmacological Research, 1989
- A rapid and sensitive assay for tyrosine-3-monooxygenase based upon the release of 3H2O and adsorption of [3H]-tyrosine by charcoalLife Sciences, 1986
- Two dopamine receptors: Biochemistry, physiology and pharmacologyLife Sciences, 1984
- Turning in circles: The neuropharmacology of rotationLife Sciences, 1976
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976